Joint Formulary & PAD

Parecoxib sodium - Pain (Palliative care)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Subcutaneous infusion
  • Subcutaneous injection (sc)
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important

For short term use

Restricted use in palliative care only, with initiation by palliative care specialist teams before transfer to primary care after stabilisation. 

Off-label use.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Parecoxib sodium
Indication :
Pain (Palliative care)
Group Name :
Keywords :
intractable cancer pain
Brand Names Include :
Dynastat
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed a change in traffic light status for parecoxib injection from RED to BLUE (with initiation by the palliative care specialist teams), for short term use, with transfer of care after stabilisation, for those patients being treated in palliative care.

Other Indications

Below are listed other indications that Parecoxib sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pain (Palliative care).